Physician profile
Ghazi M Rayan
NPI 1215921630
$3,572.95
in general payments reported to CMS, 2019-2025
12 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $145 · 2021: $444 · 2022: $328 · 2023: $845 · 2024: $617 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,255 · Education: $33.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,255.07 |
| Education | $33.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,338.60 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Pylant Medical | $486.90 | 2019-2024 | |
| Skeletal Dynamics INC | $345.50 | 2021-2025 | Geminus, Ijs, Implate |
| Acumed LLC | $336.65 | 2023-2025 | Acumed, Innate Implant, Acumed |
| Stryker Corporation | $263.18 | 2020-2021 | |
| Kerecis Limited | $207.18 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $147.13 | 2024 | Novosorb Btm |
| Trimed, INC. | $140.99 | 2023 | |
| Trice Medical, INC. | $110.34 | 2022 | |
| Checkpoint Surgical, INC | $81.05 | 2025 | Checkpoint Stimulators |
| Extremity Medical | $76.62 | 2021 | |
| P Bar Medical LLC | $38.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghazi Rayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.